EC Number |
Inhibitors |
Structure |
---|
2.7.11.21 | (-)-epigallocatechin |
- |
|
2.7.11.21 | (1R)-1-[(3S,6S,9S,12S,15S)-19-(6-[[2-(1-acetyl-1H-indol-3-yl)ethyl]amino]-6-oxohexyl)-3-carbamoyl-9-(hydroxymethyl)-12-(1H-imidazol-5-ylmethyl)-15-(2-methylpropyl)-5,8,11,14,17,20-hexaoxo-1-thia-4,7,10,13,16,19-hexaazacyclohenicosan-6-yl]ethyl phosphate |
PL-116 |
|
2.7.11.21 | (1R)-1-[(3S,6S,9S,12S,15S)-19-(6-[[2-(1-acetyl-1H-indol-3-yl)ethyl]amino]-6-oxohexyl)-3-carbamoyl-9-(hydroxymethyl)-15-(2-methylpropyl)-5,8,11,14,17,20-hexaoxo-12-[[1-(9-phenylnonyl)-1H-imidazol-5-yl]methyl]-1-thia-4,7,10,13,16,19-hexaazacyclohenicosan-6-yl]ethyl phosphate |
PL-120 |
|
2.7.11.21 | (2Z)-2-(5-bromo-2-methoxybenzylidene)-6-methyl-7H-[1,3]thiazolo[3,2-b][1,2,4]triazine-3,7(2H)-dione |
- |
|
2.7.11.21 | (3-[5-methyl-2-[(3,4,5-trimethoxyphenyl)amino]imidazo[5,1-f][1,2,4]triazin-7-yl]phenyl)(phenyl)methanone |
- |
|
2.7.11.21 | (3S)-4-amino-4-oxo-3-([[2-(4-phenylbutyl)-1-(2-phenylethyl)-1H-benzimidazol-5-yl]carbonyl]amino)butan-2-yl phosphate |
- |
|
2.7.11.21 | (4E)-4-(hydroxyimino)-5-methyl-2-(propan-2-yl)cyclohexa-2,5-dien-1-one |
i.e. poloxime, PXE |
|
2.7.11.21 | (4E)-4-(hydroxyimino)-5-methyl-2-(propan-2-yl)cyclohexa-2,5-dien-1-one |
- |
|
2.7.11.21 | (4E)-5-methyl-4-[[(2-methylbenzoyl)oxy]imino]-2-(propan-2-yl)cyclohexa-2,5-dien-1-one |
- |
|
2.7.11.21 | (4E)-5-methyl-4-[[(2-methylbenzoyl)oxy]imino]-2-(propan-2-yl)cyclohexa-2,5-dien-1-one |
poloxin |
|